November 13, 2024
2 min watch
Save
VIDEO: Treating autoimmune hepatitis with mycophenolate ‘still a cautionary tale’
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, speaks with Healio about findings from a systemic review and meta-analysis on the efficacy of mycophenolate mofetil compared with azathioprine for autoimmune hepatitis.
The data were presented at the ACG Annual Scientific Meeting.
“I want to say that this is still a cautionary tale,” Reau, the Richard B. Capps Chair of Hepatology, associate director of solid organ transplantation and section chief of hepatology at Rush University, said. “Azathioprine is still a very effective agent in many of our patients.”
Reference:
- Sawaf B, et al. Comparative efficacy of mycophenolate mofetil vs. azathioprine in autoimmune hepatitis: A systematic review and meta-analysis. Presented at: ACG Annual Scientific Meeting; Oct. 25-30, 2024; Philadelphia (hybrid meeting).
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Reau reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.